Presentation Information

[S26-3]Hypertonic intranasal adenovirus vector vaccines gain nasal epithelia access to exert strong immunogenicity

○Toshiro Hirai1,2,3,4, Yasuo Yoshioka1,2,3,4,5 (1. OTRI, Osaka Univ., 2. RIMD, Osaka Univ., 3. Grad. Sch. Pharm. Sci., Osaka Univ., 4. CAMaD, Osaka Univ., 5. BIKEN)